biolitec AG
biolitec AG: biolitec AG intends to switch from Prime Standard to Entry Standard
biolitec AG / Key word(s): Strategic Company Decision 30.11.2011 16:48 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- biolitec AG intends to switch from Prime Standard to Entry Standard Jena, November 30, 2011 - biolitec AG, based in Jena and listed in the prime standard segment of the Frankfurt stock exchange (ISIN DE0005213409), will apply for a transfer from the highly regulated exchange segment Prime Standard into the Entry Standard segment of the German stock exchange. Management and board agreed to adapt size and trading volume of the company to the market conditions. Management and board thus believe that an accreditation of the shares in the quality segment Entry Standard of the Open Market of Frankfurt Stock Exchange is appropriate and have decided to initiate the transfer into this exchange segment. In the aspired market segment, market capitalisation and costs remain within reasonable limits, and it offers shareholders high levels of transparency while relieving the management from considerable additional expenditures. The trading of the shares via the electronic platform of the German Stock Exchange XETRA and the engagement of the designated sponsor will remain in place. The application for the segment change will be submitted to Deutsche Börse AG immediately. The inclusion into the Entry Standard segment of the Open Market will take place at the point in time when the cancellation of the admission to the regulated market takes effect and is expected in the following months. 30.11.2011 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: biolitec AG Otto-Schott-Str.15 07745 Jena Germany Phone: +49 (0) 3641 519 53 0 Fax: +49 (0) 3641 519 53 33 E-mail: info@biolitec.de Internet: www.biolitec.de ISIN: DE0005213409 WKN: 521340 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Latest News
Latest Reports
Upcoming Events
No Events found
Webcasts
No Webcasts found